share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  May 31 22:58
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,250 shares of common stock on 05/31/2024, with an aggregate market value of approximately $1,001,250. The shares were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,422 shares vested on 02/17/2024 and an additional 828 shares on 02/24/2024, both from the issuer. This planned sale follows a recent transaction history where Tatsis sold 2,350 shares for a total gross proceed of $1,031,908.5 over the past three months.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,250 shares of common stock on 05/31/2024, with an aggregate market value of approximately $1,001,250. The shares were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,422 shares vested on 02/17/2024 and an additional 828 shares on 02/24/2024, both from the issuer. This planned sale follows a recent transaction history where Tatsis sold 2,350 shares for a total gross proceed of $1,031,908.5 over the past three months.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.